SPL 0.00% 9.5¢ starpharma holdings limited

Ann: Starpharma signs new DEP partnership with Chase Sun, page-7

  1. 15,610 Posts.
    lightbulb Created with Sketch. 5701
    The market doesn't appear to be overly excited about it ?

    Perhaps due to the ambiguity of the announcement - no specific product mentioned and no upfront payment ?

    Initial project is for the development of DEP® conjugates for an anti-infective drug, with an ability to add additional programs in other therapeutic areas.

    Does anybody else think this is perhaps 'treading' on AstraZeneca's toes ? Or at the very least signing away AstraZeneca's rights in China / Asia for conjugates given our AZD0466 (DEP® Bcl2/xL conjugate) deal ? @Ima Scientist - thoughts ?

    Agree @gaucau ... not overly excited about the "China" aspect .... especially given their reputation regarding accusations of patent copying / stealing - just sayin' ... have we done a deal with the devil ?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.000(0.00%)
Mkt cap ! $39.64M
Open High Low Value Volume
9.7¢ 9.7¢ 9.5¢ $19.64K 204.3K

Buyers (Bids)

No. Vol. Price($)
2 69731 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 5390 1
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.